landiolol has been researched along with Hypotension in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Aoki, H; Fukunaga, H; Horigome, H; Miura, M; Miyazaki, A; Morishima, E; Ohashi, N; Oki, K; Ono, H; Sagawa, K; Sakaguchi, H; Sato, S; Sumitomo, N; Suzuki, T; Takei, K; Ueda, H | 1 |
Kobayashi, Y; Ogiwara, K; Yasumura, R | 1 |
Deng, X; Guo, Q; He, J; He, P; Lang, Z; Li, S; Tao, G; Wang, X; Xiao, J; Xue, Z; Yang, T; Zhao, Y; Zou, Q | 1 |
Amiya, E; Endo, M; Hatano, M; Imamura, T; Inaba, T; Kinugawa, K; Komuro, I; Maki, H; Nitta, D | 1 |
Azami, T; Hirate, H; Ito, H; Katsuya, H; Sasano, H; So, M; Sobue, K; Sugiura, T | 1 |
Hidaka, K; Masuoka, M; Seki, S; Sugiura, S; Tsuchida, H | 1 |
2 trial(s) available for landiolol and Hypotension
Article | Year |
---|---|
Landiolol in the treatment of the intraoperative supraventricular tachycardia: a multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypotension; Infusions, Intravenous; Intraoperative Complications; Male; Middle Aged; Morpholines; Propanolamines; Tachycardia, Supraventricular; Treatment Outcome; Urea; Young Adult | 2015 |
The hemodynamic effects of landiolol, an ultra-short-acting beta1-selective blocker, on endotracheal intubation in patients with and without hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arthroplasty, Replacement, Hip; Blood Pressure; Female; Fentanyl; Heart Rate; Humans; Hypertension; Hypotension; Intubation, Intratracheal; Male; Middle Aged; Morpholines; Receptors, Adrenergic, beta-1; Tachycardia; Urea | 2007 |
4 other study(ies) available for landiolol and Hypotension
Article | Year |
---|---|
Control of Heart Rate in Infant and Child Tachyarrhythmia With Reduced Cardiac Function Using Landiolol (HEARTFUL) - Results of a Prospective, Multicenter, Uncontrolled Clinical Study.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Child; Heart Rate; Humans; Hypotension; Infant; Prospective Studies; Tachycardia; Urea | 2022 |
[Hyperthyroidism Diagnosed from Refractory Tachycardia and Hypotension during Surgery: A Case Report].
Topics: Blood Pressure; Female; Heart Rate; Humans; Hyperthyroidism; Hypotension; Injections, Intravenous; Middle Aged; Morpholines; Propranolol; Tachycardia; Urea | 2016 |
An Experience of Landiolol Use for an Advanced Heart Failure Patient With Severe Hypotension.
Topics: Adrenergic beta-1 Receptor Antagonists; Atrial Fibrillation; Biological Availability; Cardiomyopathy, Dilated; Electrocardiography; Heart Failure; Humans; Hypotension; Intra-Aortic Balloon Pumping; Male; Mitral Valve Insufficiency; Morpholines; Severity of Illness Index; Treatment Outcome; Urea; Ventricular Dysfunction, Left; Young Adult | 2015 |
Use of landiolol in the perioperative management of supraventricular tachycardia.
Topics: Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiotonic Agents; Dopamine; Ebstein Anomaly; Electric Countershock; Female; Heart Rate; Humans; Hypotension; Middle Aged; Morpholines; Perioperative Care; Postoperative Complications; Tachycardia, Supraventricular; Treatment Outcome; Urea | 2006 |